Rafferty Asset Management »

Peregrine Pharmaceuticals shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.5M 526k 6.70
2023-09-30 $1.8M 194k 9.44
2023-06-30 $2.9M 204k 13.97
2023-03-31 $3.3M 177k 18.76
2022-12-31 $4.4M 320k 13.77
2022-09-30 $3.3M 174k 19.12
2022-06-30 $1.9M 122k 15.26
2022-03-31 $4.4M 216k 20.37
2021-12-31 $5.3M 180k 29.18
2021-09-30 $2.5M 116k 21.57
2021-06-30 $2.1M 82k 25.65